Design Therapeutics Inc
NASDAQ:DSGN

Watchlist Manager
Design Therapeutics Inc Logo
Design Therapeutics Inc
NASDAQ:DSGN
Watchlist
Price: 5.68 USD 1.97% Market Closed
Market Cap: 321.6m USD
Have any thoughts about
Design Therapeutics Inc?
Write Note

Wall Street
Price Targets

DSGN Price Targets Summary
Design Therapeutics Inc

Wall Street analysts forecast DSGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DSGN is 8.67 USD with a low forecast of 5.05 USD and a high forecast of 12.6 USD.

Lowest
Price Target
5.05 USD
11% Downside
Average
Price Target
8.67 USD
53% Upside
Highest
Price Target
12.6 USD
122% Upside

DSGN Last Price Targets
Design Therapeutics Inc

The latest public price target was made on May 7, 2024 by Yasmeen Rahimi from Piper Sandler , who expects DSGN stock to rise by 111% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Yasmeen Rahimi
Piper Sandler
12 USD
Upside 111%
6 months ago
May 7, 2024
Piper Sandler Upgrades Design Therapeutics Inc (DSGN) to Overweight
StreetInsider
Leonid Timashev
RBC Capital
7 USD
Upside 23%
1 year ago
Aug 15, 2023
Design Therapeutics' Modified DT-216 May Have Potential, But Analyst Awaits Further Developments
Benzinga
Yasmeen Rahimi
Piper Sandler
Price Target 12 USD
Upside/Downside 111%
View Source
Leonid Timashev
RBC Capital
Price Target 7 USD
Upside/Downside 23%
View Source
Design Therapeutics Inc Competitors:
Price Targets
SVE
Synthaverse SA
52% Upside
ORGO
Organogenesis Holdings Inc
18% Upside
VCYT
Veracyte Inc
13% Upside
VXRT
Vaxart Inc
707% Upside
BCYC
Bicycle Therapeutics PLC
88% Upside
DAWN
Day One Biopharmaceuticals Inc
172% Upside
ACAD
ACADIA Pharmaceuticals Inc
56% Upside
COYA
Coya Therapeutics Inc
139% Upside

Revenue
Forecast

Revenue Estimate
Design Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Design Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Design Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DSGN's stock price target?
Price Target
8.67 USD

According to Wall Street analysts, the average 1-year price target for DSGN is 8.67 USD with a low forecast of 5.05 USD and a high forecast of 12.6 USD.

Back to Top